ADA c.273C>T ;(p.A91=)

Variant ID: 20-43255186-G-A

NM_000022.2(ADA):c.273C>T;(p.A91=)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.

Inflammatory Bowel Diseases
Colman, Ruben J RJ; Portocarrero-Castillo, Andrea A; Chona, Deepika D; Hellmann, Jennifer J; Minar, Phillip P; Rosen, Michael J MJ
Publication Date: 2021-03-15

Variant appearance in text: ADA: A91A
PubMed Link: 32426829
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK-611) in Children With Metachromatic Leukodystrophy.

Clinical Pharmacology And Therapeutics
Troy, Steven S; Wasilewski, Margaret M; Beusmans, Jack J; Godfrey, C J CJ
Publication Date: 2020-06

Variant appearance in text: ADA: A91A
PubMed Link: 31868225
Variant Present in the following documents:
  • Main text
View BVdb publication page